Specialty Medical Injectables with Reimbursement Restriction
Summary
Cigna Healthcare has expanded its Specialty Medical Injectables with Reimbursement Restriction list, requiring that certain injectables be dispensed and claims submitted through a Cigna-contracted specialty pharmacy when administered in outpatient hospital settings. One drug (Zanvastro) is already restricted as of September 28, 2026, and 11 additional drugs become restricted effective January 1, 2027. The restriction does not apply to injectables administered in provider offices, non-hospital ambulatory infusion suites, or home settings.
Get alerts when payers change rules like this one
We check Cigna and other payers every day and email you when a change matches your specialty and state.